Featured News & Press Releases: Sep 23, 2015: Conatus Announces Top-line Results From Multicenter Phase 2 Portal Hypertension
Clinical Trial in Patients With Liver Cirrhosis.
Key clinical point: Sustained virologic response is no protection against liver decompensation in patients who develop cirrhosis with severe portal hypertension
3,11] The second consideration is to establish the cause of the portal hypertension
and manage it appropriately.
Presence of portal hypertension
is one of the factors which complicates bleeding control.
This finding explains why portal hypertension
may be present in certain patients with NASH, even in the absence of established cirrhosis.
The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Portal Hypertension
Direct bypassing of extrahepatic portal venous obstruction in children: a new technique for combined hepatic portal revascularization and treatment of extrahepatic portal hypertension
Citation: Greene JA, DiPasco PJ, Koshenkov VP, Livingstone AS Portal hypertension
from nodular regenerative hyperplasia of the liver with distal splenorenal shunt.
Thus, the syndrome of portal hypertension
acquires the primary role in the prognosis for the patient's life and puts on the first place therapeutic measures to prevent and stop the esophageal-gastric bleeding.
These cases also demonstrate the wide spectrum of arterial and venous abnormalities that can result in spontaneous abdominal hemorrhage, and the case involving venous rupture is especially unusual since this patient did not have cirrhosis or portal hypertension
His medical history was also significant for arterial hypertension, hepatosplenomegaly with portal hypertension
, hypercholesterolemia, iron deficiency anemia, mild aortic stenosis, osteoporosis (T-score = −3.
According to Janna's medical report, which Al Katheri sent to Gulf News a week ago, Janna was diagnosed with 11 medical conditions by doctors from Tawam Hospital, some of which included liver failure, portal hypertension
and renal failure.
To prevent portal hypertension
with long-term complications and to accelerate resolution of the thrombus, our patient was treated with anticoagulants.
This section includes diseases such as scleroderma, lupus crest syndrome, HIV infection, portal hypertension
, and congenital heart diseases (CHD).
But this can be dangerous for patients with cirrhosis - scarring of the liver - since they already suffer from elevated liver blood pressure, or portal hypertension